BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

896 related articles for article (PubMed ID: 28617988)

  • 21. Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
    Tsoi TH; Chan CF; Chan WL; Chiu KF; Wong WT; Ng CF; Wong KL
    PLoS One; 2016; 11(9):e0162217. PubMed ID: 27598335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic Value of Peripheral Blood miR-374b-5p in Patients with Prostate Cancer.
    Pang C; Song X; Fu C; Zhang Y; Zhang Y; Liu M
    Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary microRNA-1913 to microRNA-3659 expression ratio as a non-invasive diagnostic biomarker for prostate cancer.
    Byun YJ; Piao XM; Jeong P; Kang HW; Seo SP; Moon SK; Lee JY; Choi YH; Lee HY; Kim WT; Lee SC; Cha EJ; Yun SJ; Kim WJ
    Investig Clin Urol; 2021 May; 62(3):340-348. PubMed ID: 33834642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zone.
    Kang HW; Byun YJ; Moon SM; Kim K; Piao XM; Zheng CM; Moon SK; Choi YH; Kim WT; Kim YJ; Lee SC; Yun SJ; Kim WJ
    Investig Clin Urol; 2022 Mar; 63(2):238-244. PubMed ID: 35244999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.
    Van Neste L; Hendriks RJ; Dijkstra S; Trooskens G; Cornel EB; Jannink SA; de Jong H; Hessels D; Smit FP; Melchers WJ; Leyten GH; de Reijke TM; Vergunst H; Kil P; Knipscheer BC; Hulsbergen-van de Kaa CA; Mulders PF; van Oort IM; Van Criekinge W; Schalken JA
    Eur Urol; 2016 Nov; 70(5):740-748. PubMed ID: 27108162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.
    Baumgart S; Meschkat P; Edelmann P; Heinzelmann J; Pryalukhin A; Bohle R; Heinzelbecker J; Stöckle M; Junker K
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2725-2736. PubMed ID: 31552489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Data analysis algorithm for the development of extracellular miRNA-based diagnostic systems for prostate cancer.
    Bryzgunova OE; Zaporozhchenko IA; Lekchnov EA; Amelina EV; Konoshenko MY; Yarmoschuk SV; Pashkovskaya OA; Zheravin AA; Pak SV; Rykova EY; Laktionov PP
    PLoS One; 2019; 14(4):e0215003. PubMed ID: 30970027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
    Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E
    BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association of let-7c, miR-21, miR-145, miR-182, and miR-221 with clinicopathologic parameters of prostate cancer in patients diagnosed with low-risk disease.
    Kurul NO; Ates F; Yilmaz I; Narli G; Yesildal C; Senkul T
    Prostate; 2019 Jul; 79(10):1125-1132. PubMed ID: 31045265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer.
    Roberts MJ; Chow CW; Schirra HJ; Richards R; Buck M; Selth LA; Doi SA; Samaratunga H; Perry-Keene J; Payton D; Yaxley J; Lavin MF; Gardiner RA
    Prostate; 2015 Apr; 75(5):539-49. PubMed ID: 25597828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of circulating miRNAs 21 and 375 as potential biomarkers for early diagnosis of prostate cancer.
    Gao Y; Guo Y; Wang Z; Dai Z; Xu Y; Zhang W; Liu Z; Li S
    Neoplasma; 2016; 63(4):623-8. PubMed ID: 27268927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of micro-RNA in extracellular vesicles from blood of patients with prostate cancer.
    Kim J; Cho S; Park Y; Lee J; Park J
    PLoS One; 2021; 16(12):e0262017. PubMed ID: 34972164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.
    Sequeiros T; Rigau M; Chiva C; Montes M; Garcia-Grau I; Garcia M; Diaz S; Celma A; Bijnsdorp I; Campos A; Di Mauro P; Borrós S; Reventós J; Doll A; Paciucci R; Pegtel M; de Torres I; Sabidó E; Morote J; Olivan M
    Oncotarget; 2017 Jan; 8(3):4960-4976. PubMed ID: 27903962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential of miRNAs in urinary extracellular vesicles for management of active surveillance in prostate cancer patients.
    Ramirez-Garrastacho M; Berge V; Linē A; Llorente A
    Br J Cancer; 2022 Feb; 126(3):492-501. PubMed ID: 34811506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood-based microRNAs as diagnostic biomarkers to discriminate localized prostate cancer from benign prostatic hyperplasia and allow cancer-risk stratification.
    Al-Kafaji G; Said HM; Alam MA; Al Naieb ZT
    Oncol Lett; 2018 Jul; 16(1):1357-1365. PubMed ID: 30061955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary Extracellular Vesicles and Their miRNA Cargo in Patients with Fabry Nephropathy.
    Levstek T; Mlinšek T; Holcar M; Goričar K; Lenassi M; Dolžan V; Vujkovac B; Trebušak Podkrajšek K
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum Levels of miR-223-3p and miR-223-5p in Prostate Diseases.
    Dülgeroğlu Y; Eroğlu O
    Microrna; 2020; 9(4):303-309. PubMed ID: 33155933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic Value of Circulating miR-324 for Prostate Cancer.
    Jin YY; Tong SQ; Tong M
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer.
    Kachakova D; Mitkova A; Popov E; Popov I; Vlahova A; Dikov T; Christova S; Mitev V; Slavov C; Kaneva R
    DNA Cell Biol; 2015 Mar; 34(3):189-200. PubMed ID: 25521481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miRNAs as novel biomarkers in the management of prostate cancer.
    Filella X; Foj L
    Clin Chem Lab Med; 2017 May; 55(5):715-736. PubMed ID: 26751899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.